Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan 15;124(2):456-60.
doi: 10.1002/ijc.23918.

Serum pepsinogens and risk of esophageal squamous dysplasia

Farin Kamangar  1 , Lena Diaw, Wen-Qiang Wei, Christian C Abnet, Guo-Qing Wang, Mark J Roth, Bing Liu, Ning Lu, Carol Giffen, You-Lin Qiao, Sanford M Dawsey
Affiliations

Serum pepsinogens and risk of esophageal squamous dysplasia

Farin Kamangar et al. Int J Cancer. .

Abstract

Pepsinogens are a class of endopeptidases that are secreted by the gastric epithelium and released into the circulation. Low serum pepsinogen I (PGI) and low serum pepsinogen I/pepsinogen II ratio (PGI/II ratio) are markers of gastric fundic atrophy, and have recently been shown to be associated with increased risk of esophageal squamous cell carcinoma (ESCC). We conducted the current study to test whether these markers are also associated with esophageal squamous dysplasia (ESD), the precursor lesion of ESCC. We measured serum PGI and PGII, using enzyme-linked immunosorbent assays, in 125 case subjects (patients with moderate or severe ESD) and 250 sex-matched control subjects (no ESD) selected from an endoscopic screening study in Linxian, China. We used conditional logistic regression models adjusted for age, smoking and place of residence to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs). Serum PGI showed no statistically significant association with ESD, whether analyzed as a dichotomous, ordinal (quartiles) or continuous variable. Lower serum PGI/II ratio, however, showed a dose-response association with increased risk of ESD, with an adjusted OR (95% CI) of 2.12 (1.08-4.18), comparing the lowest versus the highest quartile. The association between the lower serum PGI/II ratio and log OR of ESD was nearly linear, and the p-value for the continuous association was 0.03. Lower serum PGI/II ratio was linearly associated with higher risk of ESD. This result is consistent with recent findings that gastric atrophy may increase the risk of ESCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The association between the pepsinogen I/II ratio and the risk of moderate or severe esophageal squamous dysplasia. The pepsinogen I/II ratio was plotted on a linear scale, from high to low, and the odds of ESD was plotted on a logarithmic scale. The vertical dotted lines demarcate the quartiles (the 75th, 50th, and 25th percentiles, respectively) of the PGI/II ratio values.
See this image and copyright information in PMC

References

    1. Samloff IM, Taggart RT. Pepsinogens, pepsins, and peptic ulcer. Clin Invest Med. 1987;10:215–21. - PubMed
    1. Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, Parsonnet J. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomarkers Prev. 2001;10:107–12. - PubMed
    1. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–9. - PubMed
    1. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40. - PubMed
    1. Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, Oguro Y, Noda T, Sato T, Katoh M, Terada M, Sugimura T. Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res. 1995;86:64–71. - PMC - PubMed

Publication types

MeSH terms